Syngene Bioimaging Private Limited
About Syngene Bioimaging Private Limited
Data last updated:
Syngene Bioimaging Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33120DL2011PTC216598.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Shashank Kumar and Poonam Bakhru.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 6/1 Ff Kh. No. 455, Indira Enclave Neb Sarai, Delhi, India – 110068.
As per the financials filed for FY 2025, the company reported a revenue of ₹46,508. For the same year it recorded a net loss of ₹20,529 (net margin -44.1%) and EBITDA of -₹20,529 (EBITDA margin -44.1%). Revenue has declined at a compounded annual rate (CAGR) of 8% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Syngene Bioimaging Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 6/1 Ff Kh. No. 455, Indira Enclave Neb Sarai, Delhi, India – 110068
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Syngene Bioimaging Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Syngene Bioimaging is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
Financials of Syngene Bioimaging Private Limited
FY 2025 filings availableSyngene Bioimaging Private Limited reported revenue of ₹46,508 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years. EBITDA fell 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹20,529 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹20,529 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -44.1% | ||||
| Net Profit Margin | -44.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syngene Bioimaging Private Limited, buy the company report.
Board of directors of Syngene Bioimaging Private Limited
Syngene Bioimaging has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar Shukla Also directs: Evolve Bioplan Private Limited, Exosight Solutions LLP | Additional Director | 08 May 2024 | 2 Years 5 Months | Current |
| Shashank Kumar Also directs: Lifsyn Biospace Private Limited | Director | 08 May 2024 | 2 Years 5 Months | Current |
| Poonam Bakhru Also directs: Evolve Bioplan Private Limited, Bio Digital Private Limited | Director | 28 Mar 2011 | 15 Years 7 Months | Current |
| Vijay Bakhru Also directs: Evolve Bioplan Private Limited, Bio Digital Private Limited | Director | 28 Mar 2011 | 15 Years 7 Months | Current |
Peer comparison
Syngene Bioimaging Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Intraxis Solution Private Limited | ₹47,507 (FY 2025) | -52.0% | Hoogly, West Bengal, India | |||
| Onlinuze Bizcom Private Limited | ₹47,363 (FY 2025) | 36.0% | Gwalior, Madhya Pradesh, India | |||
| Emptus Technologies and Services Private Limited | ₹47,000 (FY 2025) | -78.0% | New Delhi, Delhi, India | |||
| Ingenious Business Marketing Services (OPC) Private Limited | ₹47,000 (FY 2025) | -88.0% | Bangalore, Karnataka, India | |||
| Shwill Medicom Private Limited | ₹46,690 (FY 2025) | -96.0% | New Delhi, Delhi, India | |||
| Syngene Bioimaging Private Limitedthis company | ₹46,508 (FY 2025) | -₹20,529 | -44.1% | Delhi, India | ||
| Guldar Organics Private Limited | ₹46,380 (FY 2025) | -62.0% | Noida, Uttar Pradesh, India | |||
| Glee Shop Online Marketing Private Limited | ₹46,363 (FY 2025) | 127.0% | Patna, Bihar, India | |||
| Ecomooj Private Limited | ₹46,278 (FY 2025) | Jhajjar, Haryana, India | ||||
| Daredrive Private Limited | ₹46,103 (FY 2025) | -44.0% | Ghoramari, Assam, India | |||
| Sanatan Basket India Private Limited | ₹46,011 (FY 2025) | -84.0% | Delhi, India |
To see the full peer comparison of Syngene Bioimaging Private Limited, buy the company report.
Auditor
Syngene Bioimaging Private Limited is audited by SINGH PAL & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH PAL & ASSOCIATES | FY 2017 | FRN0203070N |
Shareholding
The shareholding of Syngene Bioimaging Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Syngene Bioimaging Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Syngene Bioimaging Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syngene Bioimaging Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Syngene Bioimaging Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Syngene Bioimaging Private Limited has 4 board changes on record since 2011: 4 appointments. The latest: Mukesh Kumar Shukla was appointed as Additional Director on 08 May 2024.
Frequently asked questions
Syngene Bioimaging is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U33120DL2011PTC216598.
Syngene Bioimaging has 4 current directors:
- Mukesh Kumar Shukla - Additional Director
- Shashank Kumar - Director
- Poonam Bakhru - Director
- Vijay Bakhru - Director
The latest financial statements of Syngene Bioimaging on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Syngene Bioimaging is U33120DL2011PTC216598. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syngene Bioimaging was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Syngene Bioimaging by revenue are Intraxis Solution Private Limited, Onlinuze Bizcom Private Limited, Emptus Technologies and Services Private Limited, Ingenious Business Marketing Services (OPC) Private Limited, Shwill Medicom Private Limited and 5 more, all in the same principal business activity (retail trade, except of motor vehicles and motorcycles).
Mukesh Kumar Shukla was appointed as Additional Director on 08 May 2024. Shashank Kumar was appointed as Director on 08 May 2024. Poonam Bakhru was appointed as Director on 28 Mar 2011. Syngene Bioimaging has 4 board changes on record in total.
The registered office of Syngene Bioimaging is at A – 61 Ff Kh. No. 455, Indira Enclave Neb Sarai, Delhi, India – 110068.
Syngene Bioimaging operates in the trading industry, in the other wholesale segment.
The compliance status of Syngene Bioimaging is active non-compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.
Syngene Bioimaging can be reached at its registered office: A – 61 Ff Kh. No. 455, Indira Enclave Neb Sarai, Delhi, India – 110068.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
